NutriBand (NTRB) Operating Leases (2019 - 2026)
NutriBand (NTRB) posted Operating Leases of $40350.0 for Q2 2026, down 16.47% sequentially from $48305.0 in Q1 2026, and down 43.26% YoY from $71112.0 in Q2 2025.
NutriBand (NTRB) Operating Leases (2019 - 2026) Analysis & Trends
NutriBand has reported Operating Leases for 5 years, with the latest figure at $40350.0 in Q2 2026.
- Quarterly Operating Leases fell 43.26% year-over-year to $40350.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $40350.0 (down 43.26% YoY) and the FY2026 annual result came in at $48305.0, changed N/A from the prior year.
- Operating Leases slipped to $40350.0 in Q2 2026 per NTRB's latest filing, from $48305.0 in the prior quarter.
- Over five years, Operating Leases peaked at $71112.0 in Q2 2025 and troughed at $8863.0 in Q4 2023.
- A 3-year average of $40688.7 and a median of $40350.0 in 2026 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 43.26% in 2026, down 43.26% in 2026.
- Over 3 years, Operating Leases stood at $8863.0 in 2023, then jumped by 532.75% to $56081.0 in 2025, then dropped by 28.05% to $40350.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $40350.0, $48305.0, and $56081.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 40,350.00 |
| Jan 31, 2026 | 48,305.00 |
| Oct 31, 2025 | 56,081.00 |
| Jul 31, 2025 | 63,682.00 |
| Apr 30, 2025 | 71,112.00 |
| Oct 31, 2023 | 8,863.00 |
| Jul 31, 2023 | 17,529.00 |
| Apr 30, 2023 | 25,999.00 |
| Jan 31, 2023 | 34,277.00 |
| Jan 31, 2020 | 10,050.00 |
| Oct 31, 2019 | 14,906.00 |
| Jul 31, 2019 | 19,652.00 |
| Apr 30, 2019 | 5,082.00 |